Royce & Associates LP Penumbra Inc Transaction History

Royce & Associates LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$174.98 - $272.83 $2.1 Million - $3.27 Million	-12,000 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$153.32 - $191.72 $766,600 - $958,600	-5,000 Reduced 29.41%	12,000 $2.15 Million
Q2 2018 Aug 09, 2018	SELL	$112.2 - $165.95 $785,400 - $1.16 Million	-7,000 Reduced 29.17%	17,000 $2.35 Million
Q1 2018 May 14, 2018	BUY	$84.6 - $126.1 $253,799 - $378,300	3,000 Added 14.29%	24,000 $2.78 Million
Q4 2017 Feb 09, 2018	BUY	$91.55 - $115.85 $549,300 - $695,100	6,000 Added 40.0%	21,000 $1.98 Million
Q3 2017 Nov 13, 2017	BUY	$79.65 - $90.3 $398,250 - $451,500	5,000 Added 50.0%	15,000 $1.36 Million
Q2 2017 Aug 07, 2017	BUY	N/A	10,000	10,000 $878,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.